• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Crit Care Med ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019

tetano

Editor, Senior Moderator
Crit Care Med


. 2020 May 26.
doi: 10.1097/CCM.0000000000004457. Online ahead of print.
ICU and Ventilator Mortality Among Critically Ill Adults With Coronavirus Disease 2019


Sara C Auld, Mark Caridi-Scheible[SUP] 1 2 [/SUP], James M Blum[SUP] 1 2 3 4 [/SUP], Chad Robichaux[SUP] 3 4 [/SUP], Colleen Kraft[SUP] 5 6 [/SUP], Jesse T Jacob[SUP] 7 5 [/SUP], Craig S Jabaley[SUP] 1 2 [/SUP], David Carpenter[SUP] 1 [/SUP], Roberta Kaplow[SUP] 8 [/SUP], Alfonso C Hernandez-Romieu[SUP] 5 [/SUP], Max W Adelman[SUP] 5 [/SUP], Greg S Martin[SUP] 1 9 4 [/SUP], Craig M Coopersmith[SUP] 1 10 [/SUP], David J Murphy[SUP] 1 9 11 [/SUP], Emory COVID-19 Quality and Clinical Research Collaborative



Affiliations

Abstract

Objectives: To determine mortality rates among adults with critical illness from coronavirus disease 2019.
Design: Observational cohort study of patients admitted from March 6, 2020, to April 17, 2020.
Setting: Six coronavirus disease 2019 designated ICUs at three hospitals within an academic health center network in Atlanta, Georgia, United States.
Patients: Adults greater than or equal to 18 years old with confirmed severe acute respiratory syndrome-CoV-2 disease who were admitted to an ICU during the study period.
Interventions: None.
Measurements and main results: Among 217 critically ill patients, mortality for those who required mechanical ventilation was 35.7% (59/165), with 4.8% of patients (8/165) still on the ventilator at the time of this report. Overall mortality to date in this critically ill cohort is 30.9% (67/217) and 60.4% (131/217) patients have survived to hospital discharge. Mortality was significantly associated with older age, lower body mass index, chronic renal disease, higher Sequential Organ Failure Assessment score, lower PaO2/FIO2 ratio, higher D-dimer, higher C-reactive protein, and receipt of mechanical ventilation, vasopressors, renal replacement therapy, or vasodilator therapy.
Conclusions: Despite multiple reports of mortality rates exceeding 50% among critically ill adults with coronavirus disease 2019, particularly among those requiring mechanical ventilation, our early experience indicates that many patients survive their critical illness.
 
Back
Top Bottom